• Blog
  • 3D Bioprinting Market Report

    3D Bioprinting Market Report

    3D Bioprinting Market Report
    Report code - SR1227 Delivery - 2 Weeks
    Get Free Sample |
    Play Audio
    Listen
    3D Bioprinting Market Trends, Dynamics & Market Insights
    See more...

    Impact of COVID-19 on 3D Bioprinting Market

    Covid-19 has impacted the market dynamics, competition, and global...

    See more...

    Impact of COVID-19 on 3D Bioprinting Market

    Covid-19 has impacted the market dynamics, competition, and global supply chain. The revenues have gone down in 2020 and may resume an uptrend gradually from 2021. Companies optimizing their operation and strategy will sustain and beat the competition.

    Note: The summary below might not have included insights on covid impact since we have large number of reports.

    Market Insights

    The 3D Bioprinting Market is estimated to grow from USD 1.4 billion in 2020 to USD 3.8 billion by 2026 at a healthy CAGR of 18.2% during the forecast period.

    Figure: 3D Bioprinting Market Size, 2020-2026 (USD Million)

    3D-Bioprinting-Market-Forecast

    Wish to get a free sample? Register Here

    What is 3D Bioprinting?

    3D bioprinting is a form of additive manufacturing that utilizes 3D printing to fabricate biomedical parts which maximally imitate natural tissue characteristics. This printing utilizes the layer-by-layer method to deposit materials called bioinks, to create tissue-like structures which are later used in tissue and medical engineering fields.

    Key Players

    Key players operating in the 3D bioprinting market are-

    • 3D Systems Corporation (US)
    • Aspect Biosystems Ltd (Canada)
    • GeSIM GmbH (Germany)
    • Allevi Inc. (US)
    • Cyfuse Biomedical KK (Japan)
    • Envision TEC GmbH (Germany)
    • Organovo Holdings Inc. (US)
    • RegenHU SA (Switzerland)
    • Stratasys Ltd (US)
    • REGEMAT 3D (Spain)

    Market Dynamics

    The limited number of organ donors and an increasingly senior population with chronic respiratory diseases are expected to boost the demand for 3D bioprinting.

    Some other factors augmenting the market growth are-

    • Increasing R&D investment
    • Growing incidence of chronic diseases
    • Rising technological advancement

    Moreover, a surge in public and private funding to support bioprinting research activities further offer immense growth opportunities to the industry players in the coming years.

    Segment's Analysis

    Technology Trends

    Based on technology, the 3D bioprinting market is classified into inkjet-based, magnetic levitation, syringe-based, laser-based, and others. The inkjet-based segment held a significant market share in 2020 and is estimated to register a healthy CAGR during the forecast timeline. This is mainly ascribed to its ability of printing complex living organs or tissues on the culture substrates with the help of biomaterials, such as bio-inks, which bolsters the segment growth.

    Regional Trends

    By region, the North American market accounted for a significant share in 2020 and is expected to grow at a substantial CAGR in the following years. This is mainly attributed to a growing demand for 3D bioprinting as this technology has been reconnoitered for drug testing and organ transplantation. Also, the highly advanced health care industry, presence of major market players, robust research & development infrastructure, growing awareness of 3D Bioprinting, and technological developments in the region, further proliferate the regional market growth.

    COVID-19 Impact on 3D Bioprinting Market

    The COVID-19 outbreak has positively influenced the 3D bioprinting industry. The pandemic has turned the lives of people worldwide, with the number of cases increasing rapidly. The pandemic resulted in increasing coronavirus patients across the globe, putting a strain on the healthcare sector with limited hospital staff. Hence, as a reaction to the increasing cases of coronavirus, several 3D bioprinting companies are responding to the crises by offering their respective skills to ease the burden on the supply chain and governments. Due to the ever-increasing COVID-19 cases, the demand for 3D bioprinters is surging and the market for 3D bioprinting.

    Critical Questions Answered in the Report

    • What are the key trends in the 3D bioprinting market?
    • How the market (and its various sub-segments) has grown in the last five years and what would be the growth rate in the next five years?
    • What is the impact of COVID-19 on the 3D bioprinting market?
    • What are the key strategies adopted by the major vendors to lead in the 3D bioprinting market?
    • What is the market share of the top vendors?

    Wish to know more about the study? Register Here

    Report Features

    Here is the list of the group of customers that the 3D Bioprinting market hopes to have the greatest opportunity to convert-

    • 3D bioprinting vendors
    • 3D bioprinting retailers
    • Medical device companies
    • Hospitals

    Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at sales@stratviewresearch.com.

    Frequently Asked Questions (FAQs)

    The 3D bioprinting market size is expected to reach USD 3.8 billion in the coming years.

    The 3D bioprinting market is expected to grow at an impressive CAGR of 18.2% during the foreseeable future.

    3D Systems Corporation (US), Aspect Biosystems Ltd (Canada), GeSIM GmbH (Germany), Allevi Inc. (US), Cyfuse Biomedical KK (Japan), Envision TEC GmbH (Germany), Organovo Holdings Inc. (US), RegenHU SA (Switzerland), Stratasys Ltd (US), REGEMAT 3D (Spain) are the key players in the 3D bioprinting market.

    North America is expected to grow at a substantial CAGR in the 3D bioprinting market in the coming years.

    The inkjet-based segment is expected to register a healthy CAGR in the 3D bioprinting market during the forecast period.

    3D bioprinting vendors, 3D bioprinting retailers, Medical device companies, Hospitals are the target audience in the 3D bioprinting market.

    •